SHERRIE SMITH: Open Payments
NPI 1851740773 · WINCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,388 in 162 payments from 18 companies in 2025. Trend: 2023 $2,585 · 2024 $3,454 · 2025 $3,388
Food & beverage: $3,388
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $700 |
| GlaxoSmithKline, LLC. | 26 | $434 |
| Verona Pharma, Inc. | 15 | $373 |
| Avadel CNS Pharmaceuticals, LLC | 15 | $330 |
| Grifols USA, LLC | 18 | $232 |
| GENZYME CORPORATION | 10 | $204 |
| Viatris Specialty LLC | 10 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $195 |
| Insmed, Inc. | 12 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $154 |
Products named: Ohtuvayre, FASENRA, LUMRYZ, DUPIXENT, NUCALA, Prolastin-C Liquid, YUPELRI, GLASSIA.
Industry payments across TN — which companies pay providers there.
